Pre-Market Stock News (December 5, 2007)
This not all of the big stock news in pre-market trading on Tuesday evening, but these are some of the ones that 247WallSt.com is focusing on. Adolor (NASDAQ:ADLR) in pain treatment collaboration pact with Pfizer. AECOM (NYSE:ACM) announced a $63.6…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
This not all of the big stock news in pre-market trading on Tuesday evening, but these are some of the ones that 247WallSt.com is focusing on.
- Adolor (NASDAQ:ADLR) in pain treatment collaboration pact with Pfizer.
- AECOM (NYSE:ACM) announced a $63.6 million DOD contract for support services in Iraq.
- Blyth Industries (NYSE:BTH) $0.24 EPS vs. $0.12 estimates.
- Comcast (NASDAQ:CMCSA) down 4% on them cutting cable subscriber growth rates.
- DSW (NYSE:DSW) beat earnings but guidance is light.
- Fannie Mae (NYSE:FNM) cut dividend from $0.50 to $0.35; will sell $7 Billion in securities.
- Goodrich Petroleum (NYSE:GDP) priced 5.8 million shares at $23.50.
- Guess$ (NYSE:GES) $0.62 EPS vs $0.58 est.; raised 2008 and 2009 guidance.
- Hercules Offshore (NASDAQ:HERO) announced a 3-year contract for jackup rigs in India.
- Jones Soda (NASDAQ:JSDA) CEO Van Stolk is stepping down at the end of this year.
- Lexicon Pharma (NASDAQ:LXRX) starts dosing for Phase IIa Trial with LX6171 for Alzheimer’s Disease.
- Napster (NASDAQ:NAPS) is launching a new music discovery and listening channel through NTT DoCoMo.
- Raytheon (NYSE:RTN) up marginally after Jim Cramer called it a permanent bullish stock.
- Sohu.com (NASDAQ:SOHU) trading up over 10% after raised guidance.
- Synta Pharma receives (NASDAQ:SNTA) $80 million upfront payment from GlaxoSmithKline.
- United Therapeutics (NASDAQ:UTHR) said its OvaRex MAb trials failed to meet endpoints on ovarian cancer trials.
Jon C. Ogg
December 5, 2007
Jon Ogg can be reached at [email protected]; he does not own securities in the companies he covers.
Contact [email protected] for any questions or corrections.